The bioassay-guided purification of the ethanol extracts of Acmella pilosa and Cnidoscolus souzae, two plants of the native flora of the Yucatan Peninsula used in traditional medicine to treat inflammation and pain, resulted in the identification of rosmarinic acid (1) and caffeic acid (2) as the bioactive metabolites from A. pilosa, and of 7-deoxynimbidiol (4) as the major bioactive metabolite from C. souzae. Metabolites 1, 2, and 4 proved to be responsible for the antioxidant activity originally detected in the corresponding organic crude extracts; 7-deoxynimbidiol (4) showed good analgesic and anti-inflammatory activities, inhibiting the pain induced by PGE2 and reducing the edema induced by carrageenan, respectively.
Presently, 30% of the plants of the Yucatán flora have a registered medicinal use and 11% of these, which include Acmella pilosa R.K. Cansen (Asteraceae) and Cnidoscolus souzae Mc Vaugh (Euphorbiaceae), are used in Yucatán traditional medicine to relieve pain and inflammation [1] . To date there are no phytochemical reports on A. pilosa, a plant known as "tripa de gallina" in Yucatán, where the leaves of the plant are used as an anesthetic and to treat toothache [2, 3] , but phytochemical studies of A. brasilensis have resulted in the isolation of kaurenoic acid and luteolin [4] . Similarly, while the Cnidoscolus genus is known for containing vitamin C, β-carotene, coumarins, and flavonoids [5] [6] [7] , there are no reports on the phytochemistry of C. souzae, an endemic plant to the Yucatán peninsula where it is known as "chaya silvestre" and where the leaves and root of the plant are used to treat rheumatism and inflammation [2, 3] . Recently we reported the presence of both antioxidant and analgesic activities of the stem extract of A. pilosa and the root extract of C. souzae [8] ; we wish to report herein on the identification of the metabolites responsible for the biological activity detected in the organic crude extract of each plant.
Analyses of the crude extracts of A. pilosa and C. souzae showed, in each case, the presence on TLC of a major component with antioxidant activity when tested in the DPPH radical scavenging assay [9] . The bioassay-guided purification of the extract of A. pilosa resulted in the isolation and identification of rosmarinic acid (1) [10] , a bioactive metabolite commonly found in plants of the Boraginaceae and Lamiaceae families [11] , together with two minor bioactive metabolites, identified as caffeic acid (2) and rosmarinic acid ethyl ester (3) [12, 13] . However, the absence of 3 in the HPLC chromatographic profile of the acetone extract of A. pilosa confirmed it being an artifact of the extraction process.
The strong antioxidant activity observed for 1 (EC 50 0.15 μM) and 2 (EC 50 0.19 μM), when compared with that of ascorbic acid (EC 50 0.27 μM), used as positive control in the DPPH radical scavenging assay, confirmed the two compounds as being the bioactive metabolites responsible for the antioxidant activity detected in the crude extract (EC 50 0.81±0.10 mg/mL). Additionally, the fact that 1 and 2 have been reported with analgesic activity [14] [15] [16] could explain the analgesic activity previously reported for the extract of A. pilosa [8] .
Purification of the root extract of C. souzae resulted in the identification of 7-deoxynimbidiol (4), a metabolite previously isolated from Celastrus hypoleucus Oliv. Warb ex Loes (Celastraceae) and reported to have good anti-tumor activity [17] .
Although the antioxidant activity of 4 in the DPPH radical scavenging assay (EC 50 0.60 µM) indicated it being the main bioactive compound in the crude extract of C. souzae (EC 50 1.58± 0.02 mg/mL) and its semi-purified-hexane fraction (EC 50 0.75±0.03 mg/mL), the purified metabolite did not show a significant analgesic activity when tested in the assay for mechanical hyperalgesia induced by carrageenan [18] , while the crude extract showed moderate activity (30.8 %, p <0.01) in the same assay. However, testing of both the root extract of C. souzae and 4 for analgesic activity in the inhibition of pain induced by either prostaglandin E2 (PGE2) or bradykinin (BK) [19] showed both to be active against the pain induced by PGE2 (63.0 and 52.7%, p < 0.001, respectively). Additionally, the purified metabolite caused a significant reduction (40.7%, p <0.01) in the edema induced by carrageenan. These results suggest that the antiedematogenic effect of 4 might be due, at least in part, to its antioxidant activity and to the participation of PGE2. This is the first report of 4 as a secondary metabolite from C. souzae and as a bioactive metabolite with important radical scavenging, analgesic and anti-inflammatory activities.
Experimental
General: NMR spectra ( 1 H, 13 Preparative TLC purifications were carried out using glass-backed 20x20 cm silica gel plates (0.25 mm thickness, Merck). Analytical TLC analyses were carried out using aluminum-backed silica gel plates (E.M. Merck, 0.2 mm thickness); chromatograms were examined under UV light and then visualized by dipping the plates in a solution of phosphomolybdic acid (20 g) and ceric sulfate (2.5 g) in 500 mL of sulfuric acid (5%), followed by drying and heating. 
Isolation of bioactive metabolites of A. pilosa:
The AP-1 extract was suspended in 500 mL of a 3:2 H 2 O: MeOH mixture and the resulting suspension was partitioned successively between n-hexane and EtOAc. A portion (1.33 g) of the bioactive EtOAc fraction was passed through a Sephadex LH-20 column eluting with chloroform: MeOH: n-hexane 1:1:2 and 1:4:1 to yield 6 fractions (C1-C6). Fraction C4 (263.6 mg) was identified as rosmarinic acid (1) by comparing its spectroscopic data with those reported [10, 11] .
Purification of a second portion (5.25 g) of the EtOAc fraction using CC (EtOAc: acetone: n-hexane, 2:3:5) and multiple elution (3x) preparative-TLC (CH 2 Cl 2 : MeOH: n-hexane, 70:10:20) resulted in the isolation and identification of rosmarinic acid ethylester (3) (5.4 mg) and caffeic acid (2) (5.7 mg), identified by comparing their data with those in the literature [13, 14] .
Isolation of bioactive metabolites of C. souzae:
The CS-1 extract was suspended in 250 mL of a 3:2 mixture of H 2 O-EtOH and partitioned successively between n-hexane and EtOAc. VLC purification of the active n-hexane fraction (15 g), using a gradient elution with mixtures of n-hexane: acetone: MeOH produced 12 major fractions (A1-A12). Fraction A6 (2.32 g) was purified by CC eluting with n-hexane: EtOAc: MeOH (80:18:2) to produce 9 new fractions (B1-B9). Final purification of fraction B5 (289.9 mg) using flash chromatography and isocratic elution with chloroform: n-hexane: MeOH (60:35:5) resulted in the isolation of pure 7deoxynimbidiol (4) (95.7 mg), identified by comparing its spectroscopic data with those previously reported [17] .
Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay:
A calibration curve of the DPPH bleaching rate by different concentrations of ascorbic acid (Sigma-Aldrich) in methanol was prepared. Methanol was used as a blank and a 1% solution of ascorbic acid in methanol as positive control. An equal volume of the solvent used to dissolve the samples was added to the control tubes. Measurements were carried out in triplicate. The initial DPPH concentration was calculated from the calibration curve using the equation determined by linear regression. The antioxidant activity measurements were carried out by adding DPPH aliquots to a 1% methanol solution of the test samples. After 30 min, the absorbance was measured at 517 nm using a spectrophotometer; DPPH radical scavenging activity was calculated by using the following formula: % decoloration = 1 -Ae/Ac× 100, where Ae and Ac are the absorbance of the extract and the control, respectively. The antioxidant activity was expressed as EC 50 , i.e. the amount of antioxidant necessary to decrease the initial DPPH concentration by 50%.
In vivo assays: Swiss male mice weighing approximately 35g were randomly assigned to different groups (6-8 animals) and maintained on a commercial diet and water ad libidum, in an air-conditioned room at 25±2ºC (12 h light-darkness cycle, 60 to 80% humidity).
All procedures in the present study followed the "Principles of Laboratory Animal Care" from NIH publication no. 85-23 and were approved by the Animal Ethics Committee of UNIVALI (Protocol numbers 599/2007 UNIVALI). The number of animals and the intensity of noxious stimuli used were the minimum necessary to demonstrate consistent effects of the treatments.
Mechanical hyperalgesia induced by carrageenan, prostaglandin E2 (PGE2) and bradykinin (BK):
To evaluate mechanical hyperalgesia of the crude extract (1 mg/kg), semi-purified fractions (1 mg/kg), and purified metabolite (0.1 mg/kg) from C. souzae, samples were injected intraperitoneally (i.p) to mice that had received an intradermal (i.d) injection of carrageenan (300 μg/paw), PGE2 (3 nmol/paw) or BK (500 ng/paw), 30 min before initiating the experiment. The vehicle (0.9% NaCl solution) used to administer the samples was used as control (10 mL/kg). When administering BK, mice were pretreated with a subcutaneous (sc) injection of Captopril (5 mg/kg) 60 min prior to the experiment. Mechanical hyperalgesia was measured using the von Frey hairs (VFH) as follows: mice were placed individually in clear plexiglas boxes (9 × 7 × 11 cm), on elevated wire mesh platforms, to allow access to the ventral surface of the right hind-paw. The animals were allowed to acclimatize for 30 min before behavioral testing. The withdrawal response frequency was measured at different times after the injection, following 10 applications (1 s each) of VFH. The stimuli were delivered from below, to the plantar surface of the right hindpaw. The VFH of 0.6 g produces a mean withdrawal frequency of about 15%, which is considered to be an adequate value for the measurement of mechanical hyperalgesia [20] .
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Carrageenan-induced paw edema: Animals were pretreated i.p with root extract of C. souzae (1 mg/kg), 7-deoxynimbidiol (4) (0.1 mg /kg) or vehicle (0.9 % NaCl solution, 10 mL/kg); after 30 min they received an i.d injection of carrageenan (300 μg/paw) in one hindpaw (right paw). The contralateral hindpaw (left paw) received an i.d injection of saline solution and was used as control. Edema was measured using a plethysmometer (Ugo Basile) at different time points after injection of carrageenan. Inhibition of edema was expressed as the difference in μL between the right and left paws [21] .
Statistical analysis:
The percentages of inhibition were calculated using the entire time course of each experiment and are reported as the mean of inhibitions obtained for each individual experiment. The statistical significance of differences between groups was evaluated by means of a one-way analysis of variance (ANOVA) followed by Bonferroni's post hoc test and Dunnett's post hoc test. P-values lower than 0.05 (P < 0.05 or less) were considered significant. Statistical analysis was carried out using the Instant Statistical Package (Graph pad software, Inc., USA).
